Ind Swift Laboratories Quarterly Results for Trading Insights
INDSWFTLAB • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹8 Cr
QSept 2025
Ind Swift Laboratories Quarterly Results Key Highlights
- Revenue of ₹171 Cr in Sept 2025 (-52.4% vs Mar 2025, +584.0% vs Sept 2024)
- Net Profit of ₹8 Cr in Sept 2025 (-96.4% vs Mar 2025)
- EBITDA of ₹19 Cr in Sept 2025 (-91.0% vs Mar 2025)
- Operating Margin of 1.0% in Sept 2025 (+8.0pp vs Mar 2025)
- Earnings Per Share of ₹1.00 in Sept 2025 (-97.0% vs Mar 2025)
Ind Swift Laboratories Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 171 | 359 | 167 | 25 | 987 | -52.4% | 584.0% |
| Net Profit (₹ Cr) | 8 | 222 | 9 | 0 | 494 | - | - |
| EBITDA (₹ Cr) | 19 | 211 | 18 | 1 | 549 | - | - |
| EPS (₹) | 1.00 | 32.96 | 1.28 | 0.07 | 83.55 | - | - |
| Operating Margin (%) | 1.0% | -7.0% | 2.0% | -99.0% | 17.0% | - | - |
Ind Swift Laboratories Share Price Trend Around Quarterly Results
Visualize Ind Swift Laboratories's 1-year price movement across quarterly results — ideal for logging trades in Ind Swift Laboratories share price
chart using Tickjournal. All values in ₹.
Related Pages for Ind Swift Laboratories
Additional stock information and data for INDSWFTLAB
Revenue Trend (₹ Cr)
Sept 2024
25
Jun 2025
167
Mar 2025
359
Sept 2025
171
Net Profit Trend (₹ Cr)
Sept 2024
0
Jun 2025
9
Mar 2025
222
Sept 2025
8
Operating Margin Trend (%)
Sept 2024
-99.0%
Jun 2025
2.0%
Mar 2025
-7.0%
Sept 2025
1.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Ind Swift Laboratories quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1782.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 137.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 4092.2 | 3,219 | 591 | +11.3% | - | 18.4% | 233.3 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1467.9 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.7 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1242.8 | 9,135 | 1,337 | +1.1% | - | 14.6% | 76.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores